Healthcare -
Biotechnology - NASDAQ - BM
$ 20.28
3.31 %
$ 1.47 B
Market Cap
-33.8
P/E
KNSA - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative KNSA - Kiniksa Pharmaceuticals, Ltd.
129 M
LAST VALUE
22.71%
2 YEAR CAGR
43.11%
5 YEAR CAGR
0.00%
10 YEAR CAGR